RecruitingNot ApplicableNCT05112211
Multi-model Image of Doxycycline in TAO
A Multi-model Image to Evaluate the Efficacy of Doxycycline in Thyroid Associated Ophthalmopathy
Sponsor
Sun Yat-sen University
Enrollment
20 participants
Start Date
Jan 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated Ophthalmopathy by multi-modal image.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Inclusion Criteria3
- Informed consent
- Age 18-70 years old
- Diagnosed with TAO
Exclusion Criteria3
- Sight-threatening TAO with dysthyroid optic neuropathy
- Allergy of tetracycline
- Have contraindications of MRI(metal pacemaker, fake teeth, foreign body and other materials which will disturb the examination)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDoxycycline Hyclate
patients administrated with doxycycline tablets 100mg orally per day
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05112211
Related Trials
Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
NCT071245721 location
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
NCT065902201 location
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
NCT061123402 locations
Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.
NCT046621901 location
Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)
NCT063929061 location